research use only
Cat.No.S3955
|
In vitro |
0.5MNAOH : 3.02 mg/mL
DMSO
: 0.01 mg/mL
(0.05 mM)
Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 168.11 | Formula | C5H4N4O3 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 69-93-2 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | 2,6,8-Trioxypurine, 2,6,8-Trihydroxypurine, 2,6,8-Trioxopurine | Smiles | C12=C(NC(=O)N1)NC(=O)NC2=O | ||
| In vitro |
Uric acid activates NFκB in a variety of cell culture models including proximal tubular cells. Uric acid suppresses 1-α hydroxylase mRNA and protein expression in dose dependent and time dependent manner.
|
|---|---|
| In vivo |
Uric acid is synthesized mainly in the liver, intestines and the vascular endothelium as the end product of an exogenous pool of purines, and endogenously from damaged, dying and dead cells, whereby nucleic acids, adenine and guanine, are degraded into uric acid. Uric acid is a strong reactive oxygen species (ROS) and peroxynitrite scavenger and antioxidant. Uric acid may exert fundamental roles in tissue healing via initiating the inflammatory process that is necessary for tissue repair, scavenging oxygen free radicals, and mobilizing progenitor endothelial cells.
|
References |
|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05298891 | Not yet recruiting | Acromegaly |
Azienda Ospedaliero Universitaria Maggiore della Carita |
September 1 2024 | Not Applicable |
| NCT06126315 | Not yet recruiting | Amyotrophic Lateral Sclerosis |
Mario Negri Institute for Pharmacological Research|University of Sydney|FightMND |
June 2024 | Phase 2|Phase 3 |
| NCT06177821 | Recruiting | Prostatic Hyperplasia of the Medial Lobe |
Seoul National University Hospital |
June 3 2024 | Not Applicable |
| NCT06335537 | Not yet recruiting | Uric Acid Stones |
University of California Irvine |
May 2024 | Phase 1 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.